Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
mitogen-activated protein kinase kinase kinase 14 | 0.608 | 0.769 |
|
disease | 0.200 | None | 1.000 | 9 | 0 | 1996 | 2008 | |||||||||
|
IL12A antisense RNA 1 | 0.633 | 0.654 |
|
disease | 0.100 | None | 1.000 | 8 | 29 | 2009 | 2017 | |||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2018 | |||||||||
|
atherosclerosis susceptibility (lipoprotein associated) | 0.551 | 0.769 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2003 | 2020 | |||||||||
|
microRNA 506 | 0.585 | 0.615 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2012 | 2018 | |||||||||
|
gamma-glutamyltransferase light chain 5 pseudogene | 0.513 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2019 | |||||||||
|
gamma-glutamyltransferase light chain family member 3 | 0.513 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2019 | |||||||||
|
gamma-glutamyltransferase light chain 4 pseudogene | 0.513 | 0.846 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2019 | |||||||||
|
complement component 4B (Chido blood group), copy 2 | 0.670 | 0.731 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1987 | 1994 | |||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2002 | |||||||||
|
inactive glutathione hydrolase 2 | 0.559 | 0.731 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2017 | |||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1998 | 2002 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2001 | 2019 | |||||||||
|
major histocompatibility complex, class II, DR beta 3 | 0.570 | 0.885 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1992 | 1995 | |||||||||
|
Cerebellar degeneration-related autoantigen-3 | 0.472 | 0.808 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2000 | 2008 | |||||||||
|
MAPT antisense RNA 1 | 0.711 | 0.269 |
|
disease | 0.100 | None | 1.000 | 1 | 48 | 2012 | 2012 | |||||||||
|
MAPT intronic transcript 1 | 0.931 | 0.115 |
|
disease | 0.100 | None | 1.000 | 1 | 21 | 2012 | 2012 | |||||||||
|
eukaryotic translation initiation factor 4E pseudogene 2 | 1.000 | 0.077 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2009 | 2009 | |||||||||
|
LINC02210-CRHR1 readthrough | 0.570 | 0.692 |
|
disease | 0.100 | None | 1.000 | 1 | 10 | 2012 | 2012 | |||||||||
|
long intergenic non-protein coding RNA 2820 | 1.000 | 0.077 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
long intergenic non-protein coding RNA 2605 | 0.490 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
Diamond-Blackfan anemia 2 | 0.599 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | |||||||||
|
H3 histone pseudogene 23 | 0.443 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | |||||||||
|
long intergenic non-protein coding RNA 2210 | 0.861 | 0.154 |
|
disease | 0.100 | None | 1.000 | 1 | 9 | 2012 | 2012 |